Refractory celiac disease

References

• West J. Celiac disease and its complications: a time traveller's perspective. Gastroenterology 2009;136:32-4
   PubMed Web of Science ®Google Scholar
• Roshan B, Leffler DA, Jamma S, et al. The incidence and clinical spectrum of refractory celiac disease in a north american referral center. Am J Gastroenterol 2011;106:923-8
   PubMed Web of Science ®Google Scholar
• Rubio-Tapia A, Kelly DG, Lahr BD, et al. Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology 2009;136:99-107
   PubMed Web of Science ®Google Scholar
• Daum S, Ipczynski R, Schumann M, et al. High rates of complications and substantial mortality in both types of refractory sprue. Eur J Gastroenterol Hepatol 2009;21:66-70
   PubMed Web of Science ®Google Scholar
• Al-Toma A, Verbeek WH, Hadithi M, et al. Survival in refractory coeliac disease and enteropathy associated T cell lymphoma: retrospective evaluation of single centre experience. Gut 2007;56:1373-8
   PubMed Web of Science ®Google Scholar
• Malamut G, Afchain P, Verkarre V, et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 2009;136:81-90
   PubMed Web of Science ®Google Scholar
• Vahedi K, Mascart F, Mary JY, et al. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol 2003;98:1079-87
   PubMed Web of Science ®Google Scholar
• Akram S, Murray JA, Pardi DS, et al. Adult autoimmune enteropathy: mayo Clinic Rochester experience. Clin Gastroenterol Hepatol 2007;5:1282-90
   PubMed Web of Science ®Google Scholar
• Khokhar N, Gill ML. Tropical sprue: revisited. J Pak Med Assoc 2004;54:133-4
   PubMedGoogle Scholar
• Malamut G, Verkarre V, Suarez F, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol 2010;105:2262-75
   PubMed Web of Science ®Google Scholar
• Green PH, Cellier C. Celiac disease. N Engl J Med 2007;357:1731-43
   PubMed Web of Science ®Google Scholar
• Cellier C, Patey N, Mauvieux L, et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 1998;114:471-81
   PubMed Web of Science ®Google Scholar
• Cellier C, Delabesse E, Helmer C, et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000;356:203-8
   PubMed Web of Science ®Google Scholar
• Daum S, Cellier C, Mulder CJ. Refractory coeliac disease. Best Pract Res Clin Gastroenterol 2005;19:413-24
   PubMed Web of Science ®Google Scholar
• Perfetti V, Brunetti L, Biagi F, et al. TCRbeta clonality improves diagnostic yield of TCRgamma clonality in refractory celiac disease. J Clin Gastroenterol 2012;46:675-9
   PubMed Web of Science ®Google Scholar
• Daum S, Wahnschaffe U, Glasenapp R, et al. Capsule endoscopy in refractory celiac disease. Endoscopy 2007;39:455-8
   PubMed Web of Science ®Google Scholar
• Barret M, Malamut G, Rahmi G, et al. Diagnostic yield of capsule endoscopy in refractory celiac disease. Am J Gastroenterol 2012;107(10):1546-53
   PubMed Web of Science ®Google Scholar
• Vakiani E, Arguelles-Grande C, Mansukhani MM, et al. Collagenous sprue is not always associated with dismal outcomes: a clinicopathological study of 19 patients. Mod Pathol 2010;23:12-26
   PubMed Web of Science ®Google Scholar
• Goerres MS, Meijer JW, Wahab PJ, et al. Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther 2003;18:487-94
   PubMed Web of Science ®Google Scholar
• Verkarre V, Romana SP, Cellier C, et al. Recurrent partial trisomy 1q22-q44 in clonal intraepithelial lymphocytes in refractory celiac sprue. Gastroenterology 2003;125:40-6
   PubMed Web of Science ®Google Scholar
• Malamut G, Chandesris O, Verkarre V, et al. Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study. Dig Liver Dis 2013;45:377-84
   PubMedGoogle Scholar
• Hoffmann M, Vogelsang H, Kletter K, et al. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma. Gut 2003;52:347-51
   PubMed Web of Science ®Google Scholar
• Al-Toma A, Goerres MS, Meijer JW, et al. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin Gastroenterol Hepatol 2006;4:315-19
   PubMed Web of Science ®Google Scholar
• Wijmenga C. Genetic and risk for associated autoimmune disorders and refractory coeliac disease. Mastering the coeliac condition; Florence, Italy; 2012
   Google Scholar
• Mention JJ, Ben Ahmed M, Begue B, et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 2003;125:730-45
   PubMed Web of Science ®Google Scholar
• Ciccocioppo R, Di Sabatino A, Parroni R, et al. Increased enterocyte apoptosis and Fas-Fas ligand system in celiac disease. Am J Clin Pathol 2001;115:494-503
   PubMed Web of Science ®Google Scholar
• Di Sabatino A, Ciccocioppo R, D'Alo S, et al. Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in coeliac disease. Gut 2001;49:380-6
   PubMed Web of Science ®Google Scholar
• Hue S, Mention JJ, Monteiro RC, et al. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004;21:367-77
   PubMed Web of Science ®Google Scholar
• Malamut G, El Machhour R, Montcuquet N, et al. IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis. J Clin Invest 2010;120:2131-43
   PubMed Web of Science ®Google Scholar
• Holmes GK, Prior P, Lane MR, et al. Malignancy in coeliac disease–effect of a gluten free diet. Gut 1989;30:333-8
   PubMed Web of Science ®Google Scholar
• Doherty TM, Seder RA, Sher A. Induction and regulation of IL-15 expression in murine macrophages. J Immunol 1996;156:735-41
   PubMed Web of Science ®Google Scholar
• Flamand L, Stefanescu I, Menezes J. Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J Clin Invest 1996;97:1373-81
   PubMed Web of Science ®Google Scholar
• Vazquez N, Walsh TJ, Friedman D, et al. Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans. Infect Immun 1998;66:145-50
   PubMed Web of Science ®Google Scholar
• Waldmann TA, Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 1999;17:19-49
   PubMed Web of Science ®Google Scholar
• Stene LC, Honeyman MC, Hoffenberg EJ, et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am J Gastroenterol 2006;101:2333-40
   PubMed Web of Science ®Google Scholar
• Foxman EF, Iwasaki A. Genome-virome interactions: examining the role of common viral infections in complex disease. Nat Rev Microbiol 2011;9:254-64
   PubMed Web of Science ®Google Scholar
• Gough DJ, Messina NL, Clarke CJ, et al. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 2012;36:166-74
   PubMed Web of Science ®Google Scholar
• Colpitts SL, Stoklasek TA, Plumlee CR, et al. Cutting edge: the role of IFN-alpha receptor and MyD88 signaling in induction of IL-15 expression in vivo. J Immunol 2012;188:2483-7
   PubMed Web of Science ®Google Scholar
• Dafik L, Albertelli M, Stamnaes J, et al. Activation and inhibition of transglutaminase 2 in mice. PLoS One 2012;7(2):e30642
   PubMed Web of Science ®Google Scholar
• Dray X, Joly F, Lavergne-Slove A, et al. A severe but reversible refractory sprue. Gut 2006;55:1210-11
   PubMed Web of Science ®Google Scholar
• Al-Toma A, Goerres MS, Meijer JW, et al. Cladribine therapy in refractory celiac disease with aberrant T cells. Clin Gastroenterol Hepatol 2006;4:1322-7
   PubMed Web of Science ®Google Scholar
• Al-Toma A, Visser OJ, van Roessel HM, et al. Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T-cells. Blood 2007;109(5):2243-9
   PubMed Web of Science ®Google Scholar
• Tack GJ, Wondergem MJ, Al-Toma A, et al. Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy. Bone Marrow Transplant 2011;46(6):840-6
   PubMed Web of Science ®Google Scholar
• Waldmann TA. Targeting the interleukin-15 system in rheumatoid arthritis. Arthritis Rheum 2005;52:2585-8
   PubMed Web of Science ®Google Scholar
• Yokoyama S, Perera PY, Waldmann TA, et al. Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease. J Clin Immunol 2013;33:586-94
   PubMed Web of Science ®Google Scholar
• Fleischmann R, Cutolo M, Genovese MC, et al. Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs. Arthritis Rheum 2012;64:617-29
   PubMed Web of Science ®Google Scholar
• Malamut G, Meresse B, Verkarre V, et al. Large granular lymphocytic leukemia: a treatable form of refractory celiac disease. Gastroenterology 2012;143:1470-2
   PubMed Web of Science ®Google Scholar
• Malamut G, Meresse B, Kaltenbach S, et al. Small intestinal CD4 T cell lymphoma: a heterogenous entity with common pathological features. Clin Gastroenterol Hepatol 2013. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar